{"id":"W2063412360","doi":"10.3899/jrheum.091042","title":"A Double-blind, Placebo-controlled Trial of Low Dose Infliximab in Ankylosing Spondylitis","year":2010,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"ca_institutions":"Merck Canada Inc. (Canada); University of Alberta; Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Ankylosing spondylitis; Placebo; Infliximab; BASDAI; Adverse effect; Clinical endpoint; Internal medicine; Spondylitis; Surgery; Clinical trial; Gastroenterology; Tumor necrosis factor alpha; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002268005,0.001589798,0.003651713,0.0004789609,0.0007391984,0.001049799,0.0009883981,0.002610722,0.008584308],"category_scores_gemma":[0.002391669,0.000686214,0.000952616,0.0003787825,0.001704602,0.001057519,0.0004088518,0.00292493,0.001379884],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005478215,"about_ca_system_score_gemma":0.001146611,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004284489,"about_ca_topic_score_gemma":0.0007361879,"domain_scores_codex":[0.9990258,0.0005083501,0.00009088098,0.0001884634,0.00008613175,0.0001004235],"domain_scores_gemma":[0.99865,0.0003918753,0.0002619705,0.0001003675,0.0001022843,0.0004934695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9837483,0.006725818,0.0001699518,0.0004761402,0.0002173267,0.00002123169,0.00002385539,0.00006357409,0.002365357,0.00004335422,0.0003562776,0.005788796],"study_design_scores_gemma":[0.9693437,0.02957851,0.0004972319,0.00001552454,0.00007479927,0.00001271744,0.000004012429,0.0001040013,0.000153104,0.00003308594,0.0001785414,0.000004849861],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9817077,0.006014132,0.0009291956,0.0009823303,0.001417146,0.005347083,0.0009298547,0.0002592503,0.002413358],"genre_scores_gemma":[0.9793338,0.003085118,0.002237281,0.001887739,0.0009930729,0.007556061,0.001118944,0.00003167446,0.00375637],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008584308,"threshold_uncertainty_score":0.0287174,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01879422895887759,"score_gpt":0.2969922596964866,"score_spread":0.278198030737609,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}